| | | | | | | | | Sponsored | | When centrifuges lose manufacturer support, labs risk workflow disruptions and delays that can impact patient care. A new trade-in program from Drucker Diagnostics offers a solution. Trade in any StatSpin unit and receive a promotional discount on qualifying Drucker centrifuges with access to industry-leading customer service, US-based technical support, and readily available parts and accessories. |
|
|
| | |
| |
| | |
|
|
| | | | | | Our May 2026 issue has been published! Articles feature a comprehensive CE on informatics and AI, highlights from a recent lab management survey, and a profile of Lois E. Rockson, a distinguished lab innovator and educator. |
|
|
| | The life sciences industry faces significant skills shortages due to aging workforces, complex niche roles, and rapid technological advancements. This article addresses how to help bridge these gaps, fostering a more competent and adaptable workforce ready for future challenges. |
|
|
| | The Centers for Medicare & Medicaid Services (CMS) has begun collecting private payor rate data through its Fee-for-Service Data Collection System Clinical Lab Fee Schedule (CLFS) Module. Laboratories must gather their data and complete submissions by July 31. |
|
|
|
| |
| | |
|
|
| | | | | | Sponsored | | We understand what’s at stake–timely detection of transplant-associated viral targets can be critical. Our transplant-focused ASR§ portfolio is designed to support the needs of mid-volume molecular labs to develop their own LDTs without compromising flexibility or workflow efficiency. See our full menu of ASRs§ available for BK virus, CMV, EBV, HHV-6, 7 & 8, JCV, and VZV. |
|
|
| | |
| |
| | |
|
|
| | | | | | Siemens Healthineers announced its Atellica IM Testosterone II (TSTII) assay has achieved certification through the Centers for Disease Control and Prevention (CDC) Hormone Standardization Program for Total Testosterone (HoSt-TT). |
|
|
|
| |
| | |
|
|
| | | | | | Qureight has established a Scientific Advisory Board comprising leading experts in pulmonary hypertension to guide AI model development, clinical trials, and therapeutic approvals, aiming to accelerate innovation in PH treatment. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|
